Clinical Trials Directory

Trials / Completed

CompletedNCT03978546

Diagnostic Performance of Smart Supra Perimetry (The DPSSP Study)

Diagnostic Performance of Smart Supra Perimetry (SSP) in Comparison With Standard Automated Perimetry (SAP) and Ocular Coherence Tomography (OCT).

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Manchester University NHS Foundation Trust · Other Government
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Accepted

Summary

Early glaucomatous visual field changes can be missed with the routinely used Standard Automated Perimetry (SAP) and the 24-2 test pattern due to limited sampling of the central 10 degrees. While this shortcoming can be overcome with the addition of a 10-2 test, performing both tests places extra demand on the perimetric services (doubling test times) and patients. Smart Supra Perimetry (SSP) uses a new faster algorithm that can complete both 24-2 and 10-2 test patterns in a similar time frame to a single 24-2 SAP test. This comparative study aims to determine the sensitivity and specificity (i.e. diagnostic accuracy) of SSP in identifying early glaucomatous visual field loss. A sample of 100 patients with early/suspect glaucoma will undergo SAP 24-2 and 10-2 (SITA algorithm) using Humphrey visual field perimetry and SSP 24+10-2 using Henson 9000. Eyes will be categorised into 2 groups i.e., glaucoma and non-glaucoma, on the basis of structural changes to the disc as evaluated by the clinician. The sensitivity and specificity of the SAP and SSP tests will be established along with test duration. The size and location of defects established with both the SAP and SSP strategies will also be compared.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHumphrey Visual Field TestSITA Standard and 24-2 and 10-2 visual field tests
DIAGNOSTIC_TESTOptical Coherence Tomography (OCT) ScanCircle and Wide Angle Scans
DIAGNOSTIC_TESTSmart Perimetry - Henson 900024+10-2 Smart Supra test

Timeline

Start date
2019-06-11
Primary completion
2022-03-31
Completion
2022-03-31
First posted
2019-06-07
Last updated
2022-08-31

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03978546. Inclusion in this directory is not an endorsement.